Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland

CONCLUSIONS AND CLINICAL IMPLICATIONS: Our study shows that, in PwMS receiving immunomodulatory therapy, the immune response to vaccination is generally excellent. Even in immunosuppressive patients, seroconversion is satisfactory.PMID:38251955 | DOI:10.5603/pjnns.96425

Source: Neurologia i Neurochirurgia Polska - January 22, 2024 Category: Neurology Authors: Aleksandra Podlecka-Pi ętowska Janusz Sierdzi ński Monika Nojszewska Jakub Stawicki Halina Bartosik-Psujek Beata Lech Ma łgorzata Popiel Adam Perenc Alina Ku łakowska Agata Czarnowska Joanna Kulikowska Katarzyna Kapica-Topczewska Anna Jamr óz-Wiśnie Source Type: research